PPHM is also Soaring today

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM – News) today announced that the ASCO Research Foundation has awarded one of its 2009 Career Development Awards to David Gerber, MD, of the University of Texas Southwestern Medical Center for a study of the biologic effects of bavituximab and chemotherapy in patients with advanced lung cancer. Bavituximab is a monoclonal antibody with a unique mechanism that allows the body’s own immune system to recognize and act on the tumor and its supporting blood vessels, resulting in anti-cancer effects.

Strong Uptrend
PEREGRINE PHARMACEUTICALS (NASDAQ:PPHM)
Smart Scan Chart Analysis confirms that a strong uptrend is in place and that the market remains positive longer term. Strong Uptrend with money management stops. A triangle indicates the presence of a very strong trend that is being driven by strong forces and insiders.

Also take a look at this FREE trend analysis information below. Just put in PPHM your first name and e-mail and they send a report to your in-box!

FREE Trend analysis for PPHM Here

Comment on this post below.